Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C<sub>2254</sub> Variant

Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C<sub>2254</sub> Variant

Equid alphaherpesvirus-1 (EHV-1) is one of the main pathogens in horses, responsible for respiratory diseases, ocular diseases, abortions, neonatal foal death and neurological complications such as equine herpesvirus myeloencephalopathy (EHM). Current vaccines reduce the excretion and dissemination...

Full description

Bibliographic Details
Main Authors: Côme J. Thieulent, Gabrielle Sutton, Marie-Pierre Toquet, Samuel Fremaux, Erika Hue, Christine Fortier, Alexis Pléau, Alain Deslis, Stéphane Abrioux, Edouard Guitton, Stéphane Pronost, Romain Paillot
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Pathogens
Subjects:
valganciclovir
ganciclovir
EHV-1
equid alphaherpesvirus-1
herpesvirus
antiviral
Online Access:https://www.mdpi.com/2076-0817/11/5/539

Internet

https://www.mdpi.com/2076-0817/11/5/539

Similar Items